Cargando…
IGF2BP1, a Conserved Regulator of RNA Turnover in Cancer
The oncofetal IGF2 mRNA-binding protein 1 (IGF2BP1) promotes tumor progression in a variety of solid tumors and its expression is associated with adverse prognosis. The main role proposed for IGF2BP1 in cancer cells is the stabilization of mRNAs encoding pro-oncogenic factors. Several IGF2BP1-RNA as...
Autores principales: | Glaß, Markus, Misiak, Danny, Bley, Nadine, Müller, Simon, Hagemann, Sven, Busch, Bianca, Rausch, Alexander, Hüttelmaier, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019740/ https://www.ncbi.nlm.nih.gov/pubmed/33829040 http://dx.doi.org/10.3389/fmolb.2021.632219 |
Ejemplares similares
-
IGF2BP1 enhances an aggressive tumor cell phenotype by impairing miRNA-directed downregulation of oncogenic factors
por: Müller, Simon, et al.
Publicado: (2018) -
The oncofetal RNA-binding protein IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression in cancer
por: Müller, Simon, et al.
Publicado: (2020) -
The oncogenic triangle of HMGA2, LIN28B and IGF2BP1 antagonizes tumor-suppressive actions of the let-7 family
por: Busch, Bianca, et al.
Publicado: (2016) -
IGF2BP1 induces neuroblastoma via a druggable feedforward loop with MYCN promoting 17q oncogene expression
por: Hagemann, Sven, et al.
Publicado: (2023) -
IGF2BP1 is a targetable SRC/MAPK-dependent driver of invasive growth in ovarian cancer
por: Bley, Nadine, et al.
Publicado: (2020)